CJC-1295 (With DAC)

CJC-1295 (With DAC) is a synthetic, long-acting analog of growth hormone-releasing hormone (GHRH) studied for its influence on growth hormone and insulin-like growth factor 1 signaling pathways. The peptide incorporates a Drug Affinity Complex (DAC), which is designed to interact with circulating albumin and extend the compound’s stability and activity in laboratory models. Research involving CJC-1295 examines GHRH receptor activation, pulsatile growth hormone signaling, downstream IGF-1 pathway activity, peptide pharmacokinetics, and albumin-binding delivery systems. Its extended research profile distinguishes it from shorter-acting GHRH analogs and makes it useful for investigating sustained endocrine signaling in laboratory and preclinical experimental settings.

All products are designated Research Use Only (RUO). Not for human consumption. Not a drug, supplement, or food product. Purchasers assume responsibility for compliance with all applicable regulations. By purchasing you confirm you are 21 or older.